Digest Network Come funziona
Network
/
Società
Dy
Non verificato

Dyno Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaEventiIndustriaSaluteTecnica

10 comunicati stampa

Guarda tutti i comunicati
27/04/2026
Eventi
Salute
Tecnica
Biotecnologia
Farmaceutica
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/04/2026
Mercato del lavoro
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/03/2026
Eventi
Fiere
Information Technology
Biotecnologia
Tecnica
Salute
Sanità
Farmaceutica
Scienza
Software
Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/01/2026
Tecnica
Scienza
Biotecnologia
Salute
Farmaceutica
Industria
Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Tecnica
Scienza
Biotecnologia
Medicina - Varie
Salute
Eventi
Industria
Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Mercato del lavoro
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Biotecnologia
Salute
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
28/04/2025
Eventi
Fiere
Industria
Salute
Tecnica
Biotecnologia
Farmaceutica
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
13/01/2025
Mercato del lavoro
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0